WEST PHARMACEUTICAL SERVICES INC (WST) Options Risk Score

Run a full WST options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on WEST PHARMACEUTICAL SERVICES INC (WST) right now?

For a 4-week expiry, WEST PHARMACEUTICAL SERVICES INC (WST) carries an options catalyst-risk score of 63 out of 100 (MEDIUM). That score is driven by an upcoming earnings report, 8 recent news items and 81 clinical-trial catalysts falling inside the 4-week window. A mid-range score (45–69) means WST is neither clear nor obviously dangerous over this window — check which specific date is driving it before choosing a strike. The number reflects event exposure only.

WST shows an IV Rank of 13, near the low end of its one-year range — options are relatively cheap, which favours option buyers over sellers, with a current implied volatility of about 31%. IV Rank answers how WST options are priced against their own history, which is the starting point for choosing between selling and buying premium.

WST is scheduled to report earnings on 2026-10-22, which falls inside a typical monthly options expiry — expect elevated implied volatility into the event and an IV crush afterward.

WEST PHARMACEUTICAL SERVICES INC (WST) current implied volatility and IV Rank

WST's IV Rank stands at 13 right now with implied volatility around 31%, alongside a TickerRisk options-risk score of 63/100. Options on WST are inexpensive by its own recent history. Long premium and debit structures get more for their money at this level, while sellers are being paid little to carry the risk.

For what this number does and does not tell you about WST's options, see IV Rank explained.

WEST PHARMACEUTICAL SERVICES INC (WST) next earnings date — 2026-10-22

WEST PHARMACEUTICAL SERVICES INC (WST) reports earnings on 2026-10-22 — about 46 days away, which falls inside a typical options expiry window. WST's IV Rank is currently 13. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer